Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

45 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Comparison of the effect of a conventional heparin and a low molecular weight heparinoid on platelet function.
Mikhailidis DP, Barradas MA, Mikhailidis AM, Magnani H, Dandona P. Mikhailidis DP, et al. Among authors: magnani h. Br J Clin Pharmacol. 1984 Jan;17(1):43-8. doi: 10.1111/j.1365-2125.1984.tb04997.x. Br J Clin Pharmacol. 1984. PMID: 6197984 Free PMC article.
ORG 10172: a low molecular weight heparinoid anticoagulant with a long half-life in man.
Bradbrook ID, Magnani HN, Moelker HC, Morrison PJ, Robinson J, Rogers HJ, Spector RG, Van Dinther T, Wijnand H. Bradbrook ID, et al. Among authors: magnani hn. Br J Clin Pharmacol. 1987 Jun;23(6):667-75. doi: 10.1111/j.1365-2125.1987.tb03100.x. Br J Clin Pharmacol. 1987. PMID: 3606928 Free PMC article. Clinical Trial.
Double-blind randomised trial of Org 10172 low-molecular-weight heparinoid in prevention of deep-vein thrombosis in thrombotic stroke.
Turpie AG, Levine MN, Hirsh J, Carter CJ, Jay RM, Powers PJ, Andrew M, Magnani HN, Hull RD, Gent M. Turpie AG, et al. Among authors: magnani hn. Lancet. 1987 Mar 7;1(8532):523-6. doi: 10.1016/s0140-6736(87)90173-5. Lancet. 1987. PMID: 2434815 Clinical Trial.
Interaction study between Org 10172, a low molecular weight heparinoid, and acetylsalicylic acid in healthy male volunteers.
de Boer A, Danhof M, Cohen AF, Magnani HN, Breimer DD. de Boer A, et al. Among authors: magnani hn. Thromb Haemost. 1991 Aug 1;66(2):202-7. Thromb Haemost. 1991. PMID: 1722918 Clinical Trial.
The influence of Org 10172, an antithrombotic heparinoid, on urinary blood loss after transurethral prostatectomy.
Gallus A, Murphy W, Nacey J, Morris M, Sutherland P, Marshall V, Magnani H. Gallus A, et al. Among authors: magnani h. Thromb Res. 1989 Oct 15;56(2):229-38. doi: 10.1016/0049-3848(89)90165-5. Thromb Res. 1989. PMID: 2482549 Clinical Trial.
Orgaran (Org 10172) or heparin for preventing venous thrombosis after elective surgery for malignant disease? A double-blind, randomised, multicentre comparison. ANZ-Organon Investigators' Group.
Gallus A, Cade J, Ockelford P, Hepburn S, Maas M, Magnani H, Bucknall T, Stevens J, Porteous F. Gallus A, et al. Among authors: magnani h. Thromb Haemost. 1993 Oct 18;70(4):562-7. Thromb Haemost. 1993. PMID: 7509509 Clinical Trial.
Early clinical experience of a new heparinoid, Org 10172, in prevention of deep venous thrombosis.
Cade JF, Wood M, Magnani HN, Westlake GW. Cade JF, et al. Among authors: magnani hn. Thromb Res. 1987 Mar 1;45(5):497-503. doi: 10.1016/0049-3848(87)90312-4. Thromb Res. 1987. PMID: 3590088 Clinical Trial.
Prevention of deep vein thrombosis following total hip replacement by low molecular weight heparinoid.
Hoek JA, Nurmohamed MT, Hamelynck KJ, Marti RK, Knipscheer HC, ten Cate H, B├╝ller HR, Magnani HN, ten Cate JW. Hoek JA, et al. Among authors: magnani hn. Thromb Haemost. 1992 Jan 23;67(1):28-32. Thromb Haemost. 1992. PMID: 1615479 Clinical Trial.
Pharmacokinetic considerations on Orgaran (Org 10172) therapy.
Danhof M, de Boer A, Magnani HN, Stiekema JC. Danhof M, et al. Among authors: magnani hn. Haemostasis. 1992;22(2):73-84. doi: 10.1159/000216298. Haemostasis. 1992. PMID: 1379967 Review.
Orgaran in heparin-induced thrombocytopenia.
Chong BH, Magnani HN. Chong BH, et al. Among authors: magnani hn. Haemostasis. 1992;22(2):85-91. doi: 10.1159/000216299. Haemostasis. 1992. PMID: 1379968 Clinical Trial.
45 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback